Ana I. Casas
Ana I. Casas
Deputy Head of Research. WP leader H2020 program REPO-TRIAL. Department of Pharmacology
Verified email at maastrichtuniversity.nl - Homepage
Title
Cited by
Cited by
Year
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
J Egea, I Fabregat, YM Frapart, P Ghezzi, A Görlach, T Kietzmann, ...
Redox biology 13, 94-162, 2017
1822017
Reactive oxygen-related diseases: therapeutic targets and emerging clinical indications
AI Casas, VTV Dao, A Daiber, GJ Maghzal, F Di Lisa, N Kaludercic, ...
Antioxidants & redox signaling 23 (14), 1171-1185, 2015
992015
Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice
AE Freitas, J Egea, I Buendia, V Gómez-Rangel, E Parada, E Navarro, ...
Molecular neurobiology 53 (5), 3030-3045, 2016
682016
Pharmacology and clinical drug candidates in redox medicine
VTV Dao, AI Casas, GJ Maghzal, T Seredenina, N Kaludercic, ...
Antioxidants & redox signaling 23 (14), 1113-1129, 2015
652015
NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage
AI Casas, E Geuss, PWM Kleikers, S Mencl, AM Herrmann, I Buendia, ...
Proceedings of the National Academy of Sciences 114 (46), 12315-12320, 2017
642017
Simultaneous determination of 8 neurotransmitters and their metabolite levels in rat brain using liquid chromatography in tandem with mass spectrometry: Application to the …
A Wojnicz, JA Ortiz, AI Casas, AE Freitas, MG López, A Ruiz-Nuño
Clinica Chimica Acta 453, 174-181, 2016
452016
From single drug targets to synergistic network pharmacology in ischemic stroke
AI Casas, AA Hassan, SJ Larsen, V Gomez-Rangel, M Elbatreek, ...
Proceedings of the National Academy of Sciences 116 (14), 7129-7136, 2019
392019
Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke
AI Casas, PWM Kleikers, E Geuss, F Langhauser, T Adler, DH Busch, ...
The Journal of clinical investigation 129 (4), 1772-1778, 2019
262019
A diseasome cluster-based drug repurposing of soluble guanylate cyclase activators from smooth muscle relaxation to direct neuroprotection
F Langhauser, AI Casas, E Guney, J Menche, E Geuss, PWM Kleikers, ...
NPJ systems biology and applications 4 (1), 1-13, 2018
232018
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation
VTV Dao, MH Elbatreek, S Altenhöfer, AI Casas, MP Pachado, ...
Free Radical Biology and Medicine 148, 60-69, 2020
222020
Early toll‐like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro‐inflammatory phenotype in rodent and human brain ischaemia models
E Parada, AI Casas, A Palomino‐Antolin, V Gómez‐Rangel, ...
British journal of pharmacology 176 (15), 2764-2779, 2019
212019
NOS knockout or inhibition but not disrupting PSD-95-NOS interaction protect against ischemic brain damage
C Kleinschnitz, S Mencl, PWM Kleikers, MK Schuhmann, M G López, ...
Journal of Cerebral Blood Flow & Metabolism 36 (9), 1508-1512, 2016
182016
On the Clinical Pharmacology of Reactive Oxygen Species
AI Casas, C Nogales, HAM Mucke, A Petraina, A Cuadrado, AI Rojo, ...
Pharmacological reviews 72 (4), 801-828, 2020
112020
Clinical relevance of cyclic GMP modulators: A translational success story of network pharmacology
JM Oettrich, VT Dao, J Frijhoff, PWM Kleikers, AI Casas, AJ Hobbs, ...
Clinical Pharmacology & Therapeutics 99 (4), 360-362, 2016
92016
G López M, Ruiz-Nuno A (2016) Simultaneous determination of 8 neurotransmitters and their metabolite levels in rat brain using liquid chromatography in tandem with mass …
A Wojnicz, J Avendaño Ortiz, AI Casas, AE Freitas
Clin. Chim. Acta 453, 174-181, 0
7
European contribution to the study of ROS: a summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol 13: 94–162
J Egea, I Fabregat, YM Frapart, P Ghezzi, A Gorlach, T Kietzmann, ...
62017
Data supporting the rat brain sample preparation and validation assays for simultaneous determination of 8 neurotransmitters and their metabolites using liquid chromatography …
A Wojnicz, JA Ortiz, AI Casas, AE Freitas, MG López, A Ruiz-Nuño
Data in brief 7, 714-720, 2016
62016
Isoform-specific NADPH oxidase inhibition for pharmacological target validation
VT Dao, S Altenhöfer, MH Elbatreek, AI Casas, P Lijnen, MJ Meens, ...
bioRxiv, 382226, 2018
22018
Protein nitration is a physiological regulator of cardiac lactate dehydrogenase active site loop mobility and activity
C Nogales, J Frijhoff, D Thoenges, RB Sessions, A Sickmann, ...
bioRxiv, 348789, 2018
12018
A systems biology approach to cGMP suggests a prominent role for sGC in stroke: Validation by mechanism-based activation of apo-sGC in non-steal dosing coveys neuroprotection …
AI Casas, F Langhauser, VTV Dao, E Guney, PWM Kleikers, MG López, ...
BMC Pharmacology and Toxicology 16 (1), 1-1, 2015
12015
The system can't perform the operation now. Try again later.
Articles 1–20